» Articles » PMID: 39633037

Asthma and Sleep Disordered Breathing in the Pediatric Adenotonsillectomy Trial for Snoring Study

Overview
Journal Sleep Breath
Publisher Springer
Date 2024 Dec 5
PMID 39633037
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Although asthma is common in children with sleep-disordered breathing (SDB), it is unclear whether and to what extent asthma is associated with SDB-related outcomes. Our objectives are to describe risk factors for asthma among children with mild SDB (mSDB) and assess the association between asthma and the severity of sleep-related outcomes.

Methods: Cross-sectional analyses were conducted for children aged 3-12.9 years with mSDB enrolled in Pediatric Adenotonsillectomy for Snoring Children Study. Sleep-related outcomes included SDB symptoms (Pediatric Sleep Questionnaire-Sleep-Related Breathing Disorder scale (PSQ-SRBD)), SDB-specific quality of life (OSA-18), sleepiness (modified Epworth Sleepiness Score) and polysomnographic and actigraphic measures. Asthma was defined by caregiver-reported diagnosis with current asthma symptoms and medication use, or a Composite Asthma Severity Index (CASI) score ≥ 4. Asthma was further categorized into mild (CASI < 4) and moderate-to-severe (CASI ≥ 4). Regression analyses were conducted to identify asthma risk factors and estimate the associations between mild and moderate-to-severe asthma with sleep-related outcomes.

Results: The sample included 425 children (20.3%-Black, 17.4%-Hispanic; 51.7%-female). The prevalence of asthma was 19.1% (7.1% moderate-to-severe, 12.0% mild). Environmental tobacco smoke exposure and markers of atopy were associated with asthma in multivariable-adjusted analyses. Moderate-to-severe asthma was associated with increased OSA symptoms measured by PSQ-SRBD (adjusted effect estimate for moderate-to-severe vs. no asthma ( ; 95%CI): 0.08; 0.01, 0.15)) and decreased quality of life measured by OSA-18 ( ; 95%CI: 7.5; 1.20, 13.82)), and a small increase in the arousal index ( ; 95%CI: 0.80; 0.09, 1.51)).

Conclusion: Moderate-to-severe asthma was associated with worse QoL and greater SDB symptoms among children with mSDB. The co-occurrence of common risk factors for mSDB and asthma and worse symptoms and quality of life in children with both conditions support coordinated strategies for prevention and co-management of both disorders.

Clinical Trial: Pediatric Adenotonsillectomy for Snoring (PATS), NCT02562040, https://clinicaltrials.gov/study/NCT02562040.

References
1.
Marcus C, Brooks L, Draper K, Gozal D, Halbower A, Jones J . Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012; 130(3):e714-55. DOI: 10.1542/peds.2012-1672. View

2.
Bixler E, Vgontzas A, Lin H, Liao D, Calhoun S, Vela-Bueno A . Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep. 2009; 32(6):731-6. PMC: 2690559. DOI: 10.1093/sleep/32.6.731. View

3.
Prasad B, Nyenhuis S, Imayama I, Siddiqi A, Teodorescu M . Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?. Am J Respir Crit Care Med. 2019; 201(11):1345-1357. PMC: 7258643. DOI: 10.1164/rccm.201810-1838TR. View

4.
Marcus C, Moore R, Rosen C, Giordani B, Garetz S, Taylor H . A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013; 368(25):2366-76. PMC: 3756808. DOI: 10.1056/NEJMoa1215881. View

5.
Wang R, Bakker J, Chervin R, Garetz S, Hassan F, Ishman S . Pediatric Adenotonsillectomy Trial for Snoring (PATS): protocol for a randomised controlled trial to evaluate the effect of adenotonsillectomy in treating mild obstructive sleep-disordered breathing. BMJ Open. 2020; 10(3):e033889. PMC: 7073822. DOI: 10.1136/bmjopen-2019-033889. View